Navigation Links
China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009
Date:2/10/2009

BEIJING, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 31, 2008 (''3Q FY2008'') before the U.S. market opens on March 2, 2009. The Company's fiscal year ends on March 31, 2009 (''FY2008'').

Due to the sale of the business of the High Intensity Focused Ultrasound tumor therapy system (the ''HIFU Business'') in December 2008, the Company is required to report the HIFU Business as discontinued operations under United States Generally Accepted Accounting Principles. As a result, the Company requires additional time to report the results of the operations of the HIFU Business as discontinued operations in the Company's consolidated income statements for the seven quarters ended December 31, 2008 and for the fiscal year ended March 31, 2008 (''FY2007''). The Company will present these consolidated income statements in the upcoming earnings release for 3Q FY2008 on March 2, 2009.

The Company's CEO, Mr. Xiaodong Wu, CFO, Mr. Sam Tsang and CTO, Dr. Zhong Chen will host an earnings conference call at 8:00 a.m., Eastern Time on March 2, 2009 (9:00 p.m. Beijing/Hong Kong time).

    Conference Call
    The dial-in details for the live conference call are as follows:

    -- U.S. Toll Free Number 1-800-901-5247
    -- International Dial-in Number 1-617-786-4501
    Passcode: CMEDCALL

A live webcast of the conference call will be available on http://ir.chinameditech.com .

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. Eastern Time on March 3, 2009. The dial-in details for the replay are as follows:

    -- U.S. Toll Free Number 1-888-286-8010
    -- International Dial-in Number 1-617-801-6888
    Passcode: 84251245

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .

    For more information, please contact:

     Winnie Yam
     Tel:   +86-10-6530-8833
     Email: IR@chinameditech.com

'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
2. Tainted China Formula Caused High Rate of Kidney Stones in Kids
3. AMDL, Inc. Chairman & CEO Announces Expert Opinion on Chinas Economic Forecast
4. China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries
5. China Pharma Holdings, Inc., Financial Year 2008 Preview
6. Immtech Announces Sale of Property Subsidiary in China
7. Nu Skin Enterprises Receives Broader Direct Selling Authorization in China
8. Shaklee China Opens Beijing Headquarters
9. China Sky One Medical, Inc. Provides Business Update
10. China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers
11. Hard To Treat Diseases (HTDS) in Merger Talks with Mellow Hope, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: